Video On Demand

Biotech Innovation and Bayh-Dole: A Fireside Chat with Gillian M. Fenton

June 24, 2024 • 10:00 – 10:30 am EDT

Please join CSIS on Monday, June 24th from 10:00 to 10:30 am ET for a fireside chat with Gillian M. Fenton, former President of the Licensing Executives Society and Special Counsel for Innovation and Government Collaboration at GSK. Gillian will be joined by Dr. Walter G. Copan, Senior Adviser (Non-Resident) with the Renewing American Innovation Project and former Director of the National Institute of Standards and Technology (NIST), to discuss how the Bayh-Dole Act promotes innovation in the biotech industry and fits into the United States' broader economic security agenda.

This event is made possible by general support to LeadershIP.

More on the Bayh-Dole Act


Image
Photo: Alex/Adobe Stock

Photo: Alex/Adobe Stock

The Use of March-In Rights Could Undermine Innovation and National Security

The Bayh-Dole Act has been pivotal in driving U.S. innovation and economic growth. However, possible changes to march-in rights aimed at controlling drug prices could disrupt this success, posing risks to the innovation ecosystem and national competitiveness.

Commentary by Hideki Tomoshige and Sujai Shivakumar — May 23, 2024

Contact Information

Image
Gillian M. Fenton

Gillian M. Fenton

Founder and Executive Director, LST Strategies LLC
Image
Walter G. Copan
Senior Adviser (Non-resident), Renewing American Innovation Project